Clinical Trials Browser

Phase 1 × OTHER_GOV × CTL019 chimeric antigen receptor × Clear all

NCT03101709 2017-04-05

The Safety and Efficacy of CART-19 Cells in Relapse and Refractory Patients With CD19+ B-cell Lymphoma

Phase 1 Unknown

Lymphoma, B-Cell